Cheung ANY - Search Results

1

Strategic Combination Therapies for Ovarian Cancer.

Li X, Ng ASN, Mak VCY, Chan KKL, Cheung ANY, Cheung LWT. Li X, et al. Among authors: cheung lwt, cheung any. Curr Cancer Drug Targets. 2020;20(8):573-585. doi: 10.2174/1568009620666200511084007. Curr Cancer Drug Targets. 2020. PMID: 32392113 Review.

2

Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells.

Cheung LW, Au SC, Cheung AN, Ngan HY, Tombran-Tink J, Auersperg N, Wong AS. Cheung LW, et al. Endocrinology. 2006 Sep;147(9):4179-91. doi: 10.1210/en.2006-0168. Epub 2006 Jun 15. Endocrinology. 2006. PMID: 16777976

3

Beliefs about cervical cancer and human papillomavirus (HPV) and acceptability of HPV vaccination among Chinese women in Hong Kong.

Lee PW, Kwan TT, Tam KF, Chan KK, Young PM, Lo SS, Cheung AN, Ngan HY. Lee PW, et al. Prev Med. 2007 Aug-Sep;45(2-3):130-4. doi: 10.1016/j.ypmed.2007.07.013. Epub 2007 Jul 18. Prev Med. 2007. PMID: 17707077

4

Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: a qualitative-quantitative study.

Kwan TT, Chan KK, Yip AM, Tam KF, Cheung AN, Young PM, Lee PW, Ngan HY. Kwan TT, et al. Sex Transm Infect. 2008 Jun;84(3):227-32. doi: 10.1136/sti.2007.029363. Epub 2008 Feb 6. Sex Transm Infect. 2008. PMID: 18256106 Free article.

5

Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.

Liu SS, Tsang PC, Chan KY, Cheung AN, Chan KK, Leung RC, Ngan HY. Liu SS, et al. Tumour Biol. 2008;29(2):105-13. doi: 10.1159/000135690. Epub 2008 Jun 2. Tumour Biol. 2008. PMID: 18515988

6

Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications.

Kwan TT, Chan KK, Yip AM, Tam KF, Cheung AN, Lo SS, Lee PW, Ngan HY. Kwan TT, et al. BJOG. 2009 Mar;116(4):501-10. doi: 10.1111/j.1471-0528.2008.01988.x. BJOG. 2009. PMID: 19250361

7

TrkB as a therapeutic target for ovarian cancer.

Siu MK, Wong OG, Cheung AN. Siu MK, et al. Expert Opin Ther Targets. 2009 Oct;13(10):1169-78. doi: 10.1517/14728220903196787. Expert Opin Ther Targets. 2009. PMID: 19694498 Review.

8

Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer.

Wei NA, Liu SS, Leung TH, Tam KF, Liao XY, Cheung AN, Chan KK, Ngan HY. Wei NA, et al. Mol Cancer. 2009 Sep 3;8:70. doi: 10.1186/1476-4598-8-70. Mol Cancer. 2009. PMID: 19728867 Free PMC article.

9

Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.

Siu MK, Wong ES, Chan HY, Kong DS, Woo NW, Tam KF, Ngan HY, Chan QK, Chan DC, Chan KY, Cheung AN. Siu MK, et al. Int J Cancer. 2010 Jul 1;127(1):21-31. doi: 10.1002/ijc.25005. Int J Cancer. 2010. PMID: 19876919

10

Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay.

Liu SS, Leung RC, Chan KK, Cheung AN, Ngan HY. Liu SS, et al. J Clin Microbiol. 2010 Mar;48(3):758-64. doi: 10.1128/JCM.00989-09. Epub 2009 Dec 30. J Clin Microbiol. 2010. PMID: 20042614 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters